IL58673A - Process for the isolation of membrane proteins from neisseria meningitidis and vaccines containing same - Google Patents
Process for the isolation of membrane proteins from neisseria meningitidis and vaccines containing sameInfo
- Publication number
- IL58673A IL58673A IL58673A IL5867379A IL58673A IL 58673 A IL58673 A IL 58673A IL 58673 A IL58673 A IL 58673A IL 5867379 A IL5867379 A IL 5867379A IL 58673 A IL58673 A IL 58673A
- Authority
- IL
- Israel
- Prior art keywords
- isolation
- membrane proteins
- neisseria meningitidis
- containing same
- vaccines containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19782848965 DE2848965A1 (de) | 1978-11-11 | 1978-11-11 | Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine |
Publications (2)
Publication Number | Publication Date |
---|---|
IL58673A0 IL58673A0 (en) | 1980-02-29 |
IL58673A true IL58673A (en) | 1983-02-23 |
Family
ID=6054405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL58673A IL58673A (en) | 1978-11-11 | 1979-11-09 | Process for the isolation of membrane proteins from neisseria meningitidis and vaccines containing same |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0011243B1 (fr) |
JP (1) | JPS5566519A (fr) |
AT (1) | ATE857T1 (fr) |
AU (1) | AU533386B2 (fr) |
CA (1) | CA1142083A (fr) |
DE (2) | DE2848965A1 (fr) |
DK (1) | DK154841C (fr) |
ES (1) | ES485715A1 (fr) |
IL (1) | IL58673A (fr) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU563317B2 (en) * | 1982-12-02 | 1987-07-02 | Rockefeller University, The | Iga binding antibody |
US7118757B1 (en) | 1988-12-19 | 2006-10-10 | Wyeth Holdings Corporation | Meningococcal class 1 outer-membrane protein vaccine |
BR9910749A (pt) | 1998-05-29 | 2001-02-13 | Chiron Corp | Composições e vacinas imunogênicas combinadas para meningites b e c e método de induzir uma resposta imune por administração da mesma |
EP2270174A1 (fr) | 1999-05-19 | 2011-01-05 | Novartis Vaccines and Diagnostics S.r.l. | Compositions à base de combinaisons de Neisseria |
GB9918319D0 (en) | 1999-08-03 | 1999-10-06 | Smithkline Beecham Biolog | Vaccine composition |
GB9928196D0 (en) | 1999-11-29 | 2000-01-26 | Chiron Spa | Combinations of B, C and other antigens |
PT2289545T (pt) | 2000-01-17 | 2016-09-06 | Glaxosmithkline Biologicals Sa | Vacina de omv suplementada contra meningococos |
GB0103171D0 (en) * | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
KR101239242B1 (ko) | 2002-08-02 | 2013-03-11 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 항원 조합물을 포함하는 나이세리아 백신 조성물 |
GB0220194D0 (en) | 2002-08-30 | 2002-10-09 | Chiron Spa | Improved vesicles |
CU23313A1 (es) | 2002-11-27 | 2008-09-25 | Inst Finlay Ct De Investigacia | Mã0/00todo de obtenciã"n de estructuras cocleares. composiciones vacunales y adyuvantes basados en estructuras cocleares y sus intermediarios |
GB0316560D0 (en) | 2003-07-15 | 2003-08-20 | Chiron Srl | Vesicle filtration |
EP1706481A2 (fr) * | 2003-12-23 | 2006-10-04 | GlaxoSmithKline Biologicals S.A. | Vaccin |
GB0419627D0 (en) | 2004-09-03 | 2004-10-06 | Chiron Srl | Immunogenic bacterial vesicles with outer membrane proteins |
GB0424092D0 (en) | 2004-10-29 | 2004-12-01 | Chiron Srl | Immunogenic bacterial vesicles with outer membrane proteins |
JP5275983B2 (ja) | 2006-06-12 | 2013-08-28 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン |
JP5701058B2 (ja) | 2007-10-19 | 2015-04-15 | ノバルティス アーゲー | 髄膜炎菌ワクチン処方物 |
NZ587382A (en) | 2008-02-21 | 2012-01-12 | Novartis Ag | Meningococcal fhbp polypeptides |
GB0822634D0 (en) | 2008-12-11 | 2009-01-21 | Novartis Ag | Meningitis vaccines |
AU2009329193A1 (en) | 2008-12-17 | 2011-07-14 | Novartis Ag | Meningococcal vaccines including hemoglobin receptor |
TR201802380T4 (tr) | 2009-06-10 | 2018-03-21 | Glaxosmithkline Biologicals Sa | Benzonaftiridin içeren aşılar. |
WO2011024072A2 (fr) | 2009-08-27 | 2011-03-03 | Novartis Ag | Polypeptides hybrides contenant des séquences fhbp à méningocoques |
JP2013503148A (ja) | 2009-08-27 | 2013-01-31 | ノバルティス アーゲー | アルミニウム、オリゴヌクレオチドおよびポリカチオンを含むアジュバント |
TWI445708B (zh) | 2009-09-02 | 2014-07-21 | Irm Llc | 作為tlr活性調節劑之化合物及組合物 |
GB0917003D0 (en) | 2009-09-28 | 2009-11-11 | Novartis Vaccines Inst For Global Health Srl | Purification of bacterial vesicles |
AU2010302344A1 (en) | 2009-09-30 | 2012-04-26 | Novartis Ag | Expression of meningococcal fhbp polypeptides |
BR112012010531A2 (pt) | 2009-10-27 | 2019-09-24 | Novartis Ag | "polipeptídeos de modificação meningocócica fhbp" |
WO2011057148A1 (fr) | 2009-11-05 | 2011-05-12 | Irm Llc | Composés et compositions permettant de moduler l'activité des tlr-7 |
JP5814933B2 (ja) | 2009-12-15 | 2015-11-17 | ノバルティス アーゲー | 免疫増強化合物の均質な懸濁物およびその使用 |
CN102869377A (zh) | 2010-03-10 | 2013-01-09 | 葛兰素史密丝克莱恩生物有限公司 | 免疫原性组合物 |
CN102802662A (zh) | 2010-03-18 | 2012-11-28 | 诺华有限公司 | 用于脑膜炎球菌血清组b的含佐剂疫苗 |
EP2549990A1 (fr) | 2010-03-23 | 2013-01-30 | Irm Llc | Composés (lipopeptides à base de cystéine) et compositions en tant qu'agonistes des tlr2 utilisés pour traiter des infections, inflammations, maladies respiratoires entre autres |
CA2810971C (fr) | 2010-09-10 | 2020-11-03 | Novartis Ag | Developpements apportes a des vesicules membranaires externes meningococciques |
GB201015132D0 (en) | 2010-09-10 | 2010-10-27 | Univ Bristol | Vaccine composition |
EP2707009A1 (fr) | 2011-05-12 | 2014-03-19 | Novartis AG | Antipyrétiques pour améliorer la tolérabilité de vaccins à base de vésicules |
EP3299467B1 (fr) | 2012-02-02 | 2021-08-11 | GlaxoSmithKline Biologicals SA | Promoteurs pour une expression protéique accrue dans les méningocoques |
EP2823312B1 (fr) | 2012-03-08 | 2019-08-07 | GlaxoSmithKline Biologicals SA | In vitro essai d'activite des vaccins a base de proteines méningococciques |
NZ630133A (en) | 2012-06-14 | 2016-10-28 | Novartis Ag | Vaccines for serogroup x meningococcus |
RU2015106930A (ru) | 2012-09-06 | 2016-10-20 | Новартис Аг | Комбинированные вакцины с менингококком серогруппы в и к/д/с |
MX363529B (es) | 2012-09-18 | 2019-03-27 | Novartis Ag | Vesículas de membrana externa. |
BR112016019735A2 (pt) | 2014-02-28 | 2017-10-17 | Glaxosmithkline Biologicals Sa | fhbp, polipeptídeo, plasmídeo ou outro ácido nucleico, célula hospedeira, vesículas de membrana, e, composição imunogênica |
JP7104027B2 (ja) | 2016-09-02 | 2022-07-20 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 淋菌に対するワクチン |
EP3607967A1 (fr) | 2018-08-09 | 2020-02-12 | GlaxoSmithKline Biologicals S.A. | Polypeptides modifiés du méningocoque fhbp |
JP7469302B2 (ja) | 2018-11-06 | 2024-04-16 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 免疫原性組成物 |
EP3799884A1 (fr) | 2019-10-01 | 2021-04-07 | GlaxoSmithKline Biologicals S.A. | Compositions immunogènes |
GB202115077D0 (en) | 2021-10-21 | 2021-12-08 | Glaxosmithkline Biologicals Sa | Assay |
GB202115072D0 (en) | 2021-10-21 | 2021-12-08 | Glaxosmithkline Biologicals Sa | Assay |
GB202211033D0 (en) | 2022-07-28 | 2022-09-14 | Glaxosmithkline Biologicals Sa | Purification process |
-
1978
- 1978-11-11 DE DE19782848965 patent/DE2848965A1/de not_active Withdrawn
-
1979
- 1979-11-06 ES ES485715A patent/ES485715A1/es not_active Expired
- 1979-11-08 AT AT79104391T patent/ATE857T1/de not_active IP Right Cessation
- 1979-11-08 EP EP79104391A patent/EP0011243B1/fr not_active Expired
- 1979-11-08 DE DE7979104391T patent/DE2962526D1/de not_active Expired
- 1979-11-09 JP JP14456179A patent/JPS5566519A/ja active Granted
- 1979-11-09 CA CA000339541A patent/CA1142083A/fr not_active Expired
- 1979-11-09 DK DK475779A patent/DK154841C/da not_active IP Right Cessation
- 1979-11-09 IL IL58673A patent/IL58673A/xx unknown
- 1979-11-09 AU AU52682/79A patent/AU533386B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
ATE857T1 (de) | 1982-04-15 |
JPS5566519A (en) | 1980-05-20 |
EP0011243A1 (fr) | 1980-05-28 |
DK154841C (da) | 1989-06-05 |
DK475779A (da) | 1980-05-12 |
DK154841B (da) | 1988-12-27 |
DE2962526D1 (en) | 1982-05-27 |
AU533386B2 (en) | 1983-11-24 |
AU5268279A (en) | 1980-05-15 |
IL58673A0 (en) | 1980-02-29 |
EP0011243B1 (fr) | 1982-04-14 |
ES485715A1 (es) | 1980-05-16 |
CA1142083A (fr) | 1983-03-01 |
JPS6350332B2 (fr) | 1988-10-07 |
DE2848965A1 (de) | 1980-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2962526D1 (en) | Process for preparing membrane proteins from neisseria meningitidis and vaccines containing them | |
DE69423383D1 (de) | Herstellung und Verwendungen von LOS-verminderten Aussenmembran-Proteinen von Gram-negativen Kokken | |
ATE195420T1 (de) | Methode zur herstellung von eicosapentansäuren | |
JPS5750925A (en) | Preparation of pertussis toxoid | |
DE69224124D1 (de) | Verfahren zur Herstellung von Dihomo-Gamma-Linolensäure und das in dieser enthaltende Lipid | |
DE69116305D1 (de) | Verfahren zur Herstellung von Trehalulose und Isomaltulose | |
IE832529L (en) | ß-CARBOLINES, PROCESS FOR THEIR PRODUCTION AND¹PHARMACEUTICAL PREPARATIONS CONTAINING THEM | |
HUT50863A (en) | Amperometric process for quantitative statement of 1,4 dihydronicotinamid adenin dinucleotid /nadh/ in solution | |
JPS6452726A (en) | Method for removing endotoxin of pertussis, pertussis toxoid and production thereof | |
HUT44422A (en) | Method and apparatus for improving the quality of roasted coffee | |
EP0090660A3 (fr) | Vaccin anti-gonococcique | |
EP0607593A3 (fr) | Procédé d'obtention de cultures cellulaires avec un taux amélioré de cytonines autogènes. | |
DE3265664D1 (en) | Process for the production of a biochemical vaccine against salmonella fevers | |
ATA7285A (de) | Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag) | |
YU45458B (en) | Process for obtaining liquid ethanole extract of propolis | |
DE3366707D1 (en) | Preparation of glucose dehydrogenase | |
JPS57122792A (en) | Preparation of cholesterol oxidase | |
FR2620726B1 (fr) | Procede de preparation d'un extrait de jasmin et extrait obtenu | |
FR2429765A1 (fr) | Procede et agent d'adsorption pour isoler des enzymes et pour les preparer a l'etat pur | |
JPS5550890A (en) | Preparation of n-acylneuraminic acid aldolase | |
DE3887713D1 (de) | Phenanthridinderivate, Verfahren zu ihrer Herstellung und Mittel zur Ausführung des Verfahrens. | |
JPS6410950A (en) | Elimination of taste and odor of substance rich in amino acid | |
UA14449A1 (uk) | Спосіб отримаhhя паhтокриhа для іh'єкцій | |
JPS5682095A (en) | Purification of fatty acid produced through fermentation process | |
JPS55102497A (en) | Treatment of waste water containing thiocyanogen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HP | Change in proprietorship | ||
KB | Patent renewed |